Our thanks to every member of the Committee, on both sides of the vote, for taking the evidence and the questions seriously
For the laboratory researcher, the two peptides remain interesting tools provided they are used for what they truly are: compounds research use only With a robust but asymmetrical preclinical literature (35 AJSM 2026 studies for BPC-157, muscle/cardiac base for TB-500), and extremely limited human data on both sides, maintaining this nuance helps avoid claims not supported by science and properly position the two peptides within a well-designed research protocol
Share your health history and goals in our secure online questionnaire
We focus on transparency, bioavailability, and science-forward formulations so you never have to guess if your supplements are working
37.0 37.1 Shirasaki F, Makhluf HA, LeRoy C, Watson DK, Trojanowska M (December 1999)